Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genome
Biotech
Founder-led biotech raises $11M for preclinical cancer portfolio
Talus Bio has raised about $11 million to advance a preclinical portfolio and platform that targets historically hard-to-reach transcription factors.
Gabrielle Masson
Aug 20, 2024 11:05am
Rome's 'dark genome' drug reduces autoimmune markers in mice
Nov 17, 2023 1:03pm
Collins, after 12 years at the NIH helm, will exit
Oct 5, 2021 9:20am
Doudna's team identifies new 'hypercompact' CRISPR enzyme
Jul 16, 2020 2:00pm
ArsenalBio joins next-gen cell therapy field with $85M A round
Oct 17, 2019 7:00am
Sangamo Therapeutics bags Cytokinetics' exec as new CMO
Oct 1, 2019 7:45am
